[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Rousta et al., 2021 - Google Patents

The emulsifier carboxymethylcellulose induces more aggressive colitis in humanized mice with inflammatory bowel disease microbiota than polysorbate-80

Rousta et al., 2021

View HTML
Document ID
7635571262960296049
Author
Rousta E
Oka A
Liu B
Herzog J
Bhatt A
Wang J
Habibi Najafi M
Sartor R
Publication year
Publication venue
Nutrients

External Links

Snippet

Commonly used synthetic dietary emulsifiers, including carboxymethylcellulose (CMC) and polysorbate-80 (P80), promote intestinal inflammation. We compared abilities of CMC vs. P80 to potentiate colitis and impact human microbiota in an inflammatory environment using …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Liu et al. Astaxanthin prevents alcoholic fatty liver disease by modulating mouse gut microbiota
Di Iorio et al. Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika Study)
Konstantinidis et al. Effects of antibiotics upon the gut microbiome: a review of the literature
Schierová et al. Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy
Chiu et al. Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis
Sroka-Oleksiak et al. Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: a pilot study
Aitoro et al. Gut microbiota as a target for preventive and therapeutic intervention against food allergy
Gan et al. Curcumin and resveratrol regulate intestinal bacteria and alleviate intestinal inflammation in weaned piglets
Matijašić et al. Modulating composition and metabolic activity of the gut microbiota in IBD patients
Mazur-Bialy et al. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of irisin, adiponectin and proinflammatory biomarkers
Rousta et al. The emulsifier carboxymethylcellulose induces more aggressive colitis in humanized mice with inflammatory bowel disease microbiota than polysorbate-80
Navarro-López et al. Probiotics in the therapeutic arsenal of dermatologists
Lee et al. Lactobacillus plantarum HY7715 ameliorates sarcopenia by improving skeletal muscle mass and function in aged Balb/c mice
de la Visitación et al. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation
Tulyeu et al. Probiotics prevents sensitization to oral antigen and subsequent increases in intestinal tight junction permeability in juvenile–young adult rats
Gajęcka et al. The expression of type-1 and type-2 nitric oxide synthase in selected tissues of the gastrointestinal tract during mixed mycotoxicosis
Feng et al. Heat-killed Bifidobacterium bifidum B1628 may alleviate dextran sulfate sodium-induced colitis in mice, and the anti-inflammatory effect is associated with gut microbiota modulation
Hata et al. Gut microbiota changes by an SGLT2 inhibitor, luseogliflozin, alters metabolites compared with those in a low carbohydrate diet in db/db mice
Issara-Amphorn et al. Candida administration in bilateral nephrectomy mice elevates serum (1→ 3)-β-D-glucan that enhances systemic inflammation through energy augmentation in macrophages
Zhang et al. Sex-specific differences in the gut microbiome in response to dietary fiber supplementation in IL-10-deficient mice
Kaewduangduen et al. Blood bacteria-free DNA in septic mice enhances LPS-induced inflammation in mice through macrophage response
Kim et al. Gardenia Jasminoides ameliorates antibiotic-associated aggravation of DNCB-induced atopic dermatitis by restoring the intestinal microbiome profile
Huang et al. Increase in akkermansiaceae in gut microbiota of prostate cancer-bearing mice
Polidori et al. Characterization of gut microbiota composition in type 2 diabetes patients: A population-based study
Houron et al. Gut microbiota reshaped by pectin treatment improves liver steatosis in obese mice